Taisho Pharmaceutical Co., Ltd selected site
Taisho Pharmaceutical Co., Ltd selected site
Tokyo, Japan3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders | Hyperphosphatemia Patients on Hemodialysis | Recruiting | Phase 3 | 2026-04-17 | NCT07285291 | |
| A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment | Patients With Mild or Moderate Hepatic Impairment | Recruiting | Phase 1 | 2026-01-09 | NCT07231029 | |
| A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis | Hyperphosphatemia Patients on Hemodialysis | Recruiting | Phase 3 | 2025-12-16 | NCT07285304 |